Daniel D. Long, SVP, Drug Discovery at Septerna, Inc. (SEPN), sold 3,333 shares at $37.83 ($126K) on 2026-09-01, disclosed to the SEC on 2026-09-03.
Scheduled sale ($126k) by SVP, Drug Discovery under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SEPN | SELL | 2026-06-24 | $533K | — | Filing → |
| SEPN | SELL | 2025-11-13 | $126K | — | Filing → |